^
BIOMARKER:

KRAS G12A

i
Other names: KRAS, KRAS1, KRAS2, Kirsten rat sarcoma viral oncogene homolog
Entrez ID:
Related biomarkers:
KRAS G12A
CRC
cetuximab
Resistant: B - Late Trials
KRAS G12A
CRC
panitumumab
Resistant: B - Late Trials
KRAS G12A
CML
GT19077
Sensitive: C3 – Early Trials
KRAS G12A
Ovarian Serous Adenocarcinoma
VS-6766 + VS-6063
Sensitive: C3 – Early Trials
KRAS G12A
HCC
sorafenib + BAY86-9766
Sensitive: C3 – Early Trials
KRAS G12A
NSCLC
erlotinib
Resistant: C3 – Early Trials
KRAS G12A
NSCLC
Immunotherapy
Sensitive: C3 – Early Trials
KRAS G12A
NSCLC
regorafenib
Sensitive: C4 – Case Studies
KRAS G12A
Lymphoma
GT19077
Sensitive: D – Preclinical
KRAS G12A
Multiple Myeloma
GT19077
Sensitive: D – Preclinical
KRAS G12A
AML
GT19077
Sensitive: D – Preclinical
KRAS G12A
CLL
GT19077
Sensitive: D – Preclinical
KRAS G12A
CRC
sunitinib
Resistant: D – Preclinical